The Autumn 2018 Issue of Nutraceuticals Now is now available.
The following articles are available on this website:
- Triskelion: Research for better living
- Joint Health: Staying Ahead in an Evolving Healthy Aging Market
UAS Labs has a long, important pedigree in probiotics. Founded in 1979 by Chairman Dr. Dash, the producer of premium probiotics has been at the forefront of the industry for almost as long as the industry has existed. Today, with equity partners and new management, UAS Laboratories, LLC has expanded its operations, added a probiotic fermentation plant, acquired Micropharma and Nebraska Culture, and added new probiotic strains and products. It continues to break new ground through its state-of-the-art manufacturing facilities, gold standard clinical trials, proven probiotic strains and development of condition-specific probiotics.
In recent years, notably since new owners took over the company in 2013, UAS Labs’ commitment to pioneering practices has led them to make outsized investments. These investments include growth and process improvements in their Wausau, Wisconsin, USA manufacturing plant, the acquisition of another probiotic manufacturer, the opening of their new, state-of-the art fermentation facility, licensing rights to clinically proven strains and ongoing clinical research. These investments have bolstered UAS Labs’ status as a producer of premium probiotics with deep in-house expertise and proprietary R&D technologies — a type of company that is almost as rare today as it was in 1979.
Investing in manufacturing excellence
UAS Labs, also known as The Probiotic Company, is built upon its probiotic-only manufacturing facilities. Since UAS Labs’ CEO Kevin Mehring and CSO Dr Greg Leyer took charge of the company in 2013, they have made a considerable Investment to ensure the stability and viability of their probiotic solutions.
This article is available in full in the SSW Special Issue 2018 of Nutraceuticals Now